Botulism immune globulin Side Effects
Medically reviewed by Drugs.com. Last updated on Aug 22, 2023.
Applies to botulism immune globulin: parenteral powder for iv infusion.
Side effects include:
Erythematous rash.
For Healthcare Professionals
Applies to botulism immune globulin: intravenous powder for injection.
Cardiovascular
Very common (10% or more): Blood pressure increased (75%), pallor (28%), cardiac murmur (15%)
Common (1% to 10%): Tachycardia NOS, peripheral coldness
Postmarketing reports: Cardiac arrest, vascular collapse, hypotension, thromboembolism[Ref]
Respiratory
Very common (10% or more): Atelectasis (39%), rhonchi (34%), nasal congestion (18%), oxygen saturation decreased (17%), cough (13%), rales (13%), breath sounds decreased (10%)
Common (1% to 10%): Stridor, dyspnea NOS, tachypnea, respiratory arrest
Postmarketing reports: Apnea, acute respiratory distress syndrome, transfusion related acute lung injury, cyanosis, hypoxemia, pulmonary edema, bronchospasm[Ref]
Gastrointestinal
Very common (10% or more): Dysphagia (65%), loose stools (25%), vomiting (20%), abdominal distension (11%)
Postmarketing reports: Abdominal pain[Ref]
Dermatologic
Very common (10% or more): Dermatitis contact (24%), rash erythematous (22%)
Postmarketing reports: Stevens-Johnson syndrome, epidermolysis, erythema multiforme, bullous dermatitis[Ref]
Other
Very common (10% or more): Edema (18%), pyrexia (17%), body temperature decreased (16%)
Postmarketing reports: Rigors[Ref]
Metabolic
Very common (10% or more): Dehydration (10%)
Common (1% to 10%): Hyponatremia, metabolic acidosis[Ref]
Immunologic
Very common (10% or more): Otitis media (11%), pneumonia (11%)
Common (1% to 10%): Lower respiratory tract infection, oral candidiasis, urinary tract infection[Ref]
Local
Common (1% to 10%): Injection site reaction, injection site erythema[Ref]
Hematologic
Common (1% to 10%): Hemoglobin decreased, anemia
Postmarketing reports: Pancytopenia, leukopenia, hemolysis, positive direct antiglobulin (Coombs) test[Ref]
Nervous system
Postmarketing reports: Coma, loss of consciousness, seizures, tremor[Ref]
Hepatic
Postmarketing reports: Hepatic dysfunction[Ref]
Musculoskeletal
Postmarketing reports: Back pain[Ref]
Psychiatric
Very common (10% or more): Irritability (41%), agitation (10%)[Ref]
More about botulism immune globulin
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: immune globulins
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
References
1. Product Information. BabyBIG (botulism immune globulin). FFF Enterprises. 2008.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.